DL-01 formic is a next-generation ADC linker-payload featuring acridine-thiosemicarbazone chemistry for targeted cancer therapy. Delivers potent Topoisomerase IIα inhibition via DNA intercalation with proven leukemic cell cytotoxicity and exceptional safety profile (LD50 >2000mg/kg).
Usually ships within 24 hours.